iSpecimen Statistics

Total Valuation

iSpecimen has a market cap or net worth of $3.14 million. The enterprise value is $2.66 million.

Market Cap	3.14M
Enterprise Value	2.66M

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025, before market open.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

iSpecimen has 2.50 million shares outstanding. The number of shares has increased by 159.38% in one year.

Current Share Class	2.50M
Shares Outstanding	2.50M
Shares Change (YoY)	+159.38%
Shares Change (QoQ)	+105.35%
Owned by Insiders (%)	1.59%
Owned by Institutions (%)	4.17%
Float	2.46M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.18
Forward PS	n/a
PB Ratio	1.89
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.33
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.31, with a Debt / Equity ratio of 0.18.

Current Ratio	0.31
Quick Ratio	0.28
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-48.14

Financial Efficiency

Return on equity (ROE) is -265.37% and return on invested capital (ROIC) is -158.94%.

Return on Equity (ROE)	-265.37%
Return on Assets (ROA)	-73.40%
Return on Invested Capital (ROIC)	-158.94%
Return on Capital Employed (ROCE)	-590.90%
Revenue Per Employee	$335,776
Profits Per Employee	-$468,920
Employee Count	24
Asset Turnover	0.83
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.35% in the last 52 weeks. The beta is 1.69, so iSpecimen's price volatility has been higher than the market average.

Beta (5Y)	1.69
52-Week Price Change	-80.35%
50-Day Moving Average	1.20
200-Day Moving Average	2.95
Relative Strength Index (RSI)	55.52
Average Volume (20 Days)	37,581

Short Selling Information

The latest short interest is 31,386, so 1.26% of the outstanding shares have been sold short.

Short Interest	31,386
Short Previous Month	62,240
Short % of Shares Out	1.26%
Short % of Float	1.28%
Short Ratio (days to cover)	0.72

Income Statement

In the last 12 months, iSpecimen had revenue of $8.06 million and -$11.25 million in losses. Loss per share was -$9.56.

Revenue	8.06M
Gross Profit	3.10M
Operating Income	-11.37M
Pretax Income	-10.20M
Net Income	-11.25M
EBITDA	-11.11M
EBIT	-11.37M
Loss Per Share	-$9.56

Full Income Statement

Balance Sheet

The company has $782,563 in cash and $300,147 in debt, giving a net cash position of $482,416 or $0.19 per share.

Cash & Cash Equivalents	782,563
Total Debt	300,147
Net Cash	482,416
Net Cash Per Share	$0.19
Equity (Book Value)	1.67M
Book Value Per Share	0.67
Working Capital	-3.39M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.29 million and capital expenditures -$47,410, giving a free cash flow of -$7.33 million.

Operating Cash Flow	-7.29M
Capital Expenditures	-47,410
Free Cash Flow	-7.33M
FCF Per Share	-$2.94

Full Cash Flow Statement

Margins

Gross margin is 38.45%, with operating and profit margins of -141.04% and -139.65%.

Gross Margin	38.45%
Operating Margin	-141.04%
Pretax Margin	-139.65%
Profit Margin	-139.65%
EBITDA Margin	-137.83%
EBIT Margin	-141.04%
FCF Margin	n/a

Dividends & Yields

iSpecimen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-159.38%
Shareholder Yield	-159.38%
Earnings Yield	-357.94%
FCF Yield	-233.28%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 16, 2024. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Sep 16, 2024
Split Type	Reverse
Split Ratio	0.05:1

Scores

iSpecimen has an Altman Z-Score of -19.59 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-19.59
Piotroski F-Score	2